Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Tigenix to Get 4.95 Million-Euro Loan for Crohn’s Fistula Study

Oct. 3 (Bloomberg) -- TiGenix NV’s Cellerix unit will get a 4.95 million-euro loan from the “Madrid Network” to finance the company’s phase III study for complex perianal fistulas in Crohn’s disease patients, TiGenix said today in an e-mailed statement.

Link to Company News:{TIG BB <Equity> CN <GO>}

To contact the editor responsible for this story: Andrew Clapham at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.